Literature DB >> 18429655

Economic evaluation of interventions to treat opiate dependence : a review of the evidence.

Christopher M Doran1.   

Abstract

Opiate dependence imposes a significant economic burden on society in terms of treatment-related costs and prevention services, other healthcare costs, the work absenteeism of patients, productivity loss arising from premature death of patients, costs associated with crime, and social welfare expenditure. The objective of this research is to review the literature on economic evaluation of treatment of opiate dependence (including detoxification, maintenance and psychosocial support).A literature review was performed on several electronic databases, including MEDLINE (Ovid), Cochrane Database of Systematic Reviews, NHS Economic Evaluation Library Database (via Cochrane Library), Web of Science, Social Science Citations Index, EMBASE and PsycINFO. A sensitive approach was used in order to maximize the number of articles retrieved; no language or publication year limitations were applied to the searches. A combination of subject heading term searches and natural word searches were used. The Drummond checklist was applied to assess the quality of economic evaluations.A total of 259 articles were considered relevant, with eight review studies identified. The treatment spectrum ranged from detoxification to maintenance treatments involving the use of agonist and/or antagonist treatments. The evidence suggests that, although the quality of economic evaluations is reasonably good, there is a dearth of knowledge about the cost effectiveness of treatments for opiate dependence. The majority of the literature reporting the results of cost-effectiveness analyses used surrogate outcome measures and adopted a narrow treatment provider perspective. Studies that have conducted cost-benefit analyses, in spite of methodological divergences, generally adopted a societal perspective and consistently demonstrated positive economic returns from opiate treatment. A paucity of research examined the extent to which psychosocial or behavioural interventions support or replace conventional pharmacological approaches. Economic evaluation provides a useful framework to assist policy makers in allocating resources across competing needs. Opiate dependence is a considerable burden on society's resources, and treatment provides a cost-beneficial solution to address these consequences. However, to better inform the decision-making process, researchers must continue to produce high-quality, methodological, comparable and scientifically credible economic evaluations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18429655     DOI: 10.2165/00019053-200826050-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  66 in total

1.  Changes in criminal activity after entering methadone maintenance.

Authors:  J Bell; W Hall; K Byth
Journal:  Br J Addict       Date:  1992-02

2.  Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

Authors:  Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser
Journal:  Health Serv Res       Date:  2006-02       Impact factor: 3.402

3.  Are supplementary services provided during methadone maintenance really cost-effective?

Authors:  M K Kraft; A B Rothbard; T R Hadley; A T McLellan; D A Asch
Journal:  Am J Psychiatry       Date:  1997-09       Impact factor: 18.112

4.  Cost-effectiveness analysis of maintenance agonist treatments in the NEPOD.

Authors:  Christopher M Doran; Marian Shanahan; Erol Digiusto; Susannah O'Brien; Richard P Mattick
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2006-08       Impact factor: 2.217

5.  Treatment Outcome Prospective Study (TOPS): client characteristics and behaviors before, during, and after treatment.

Authors:  R L Hubbard; J V Rachal; S G Craddock; E R Cavanaugh
Journal:  NIDA Res Monogr       Date:  1984

6.  Methadone maintenance and drug-related crime.

Authors:  J Bell; R Mattick; A Hay; J Chan; W Hall
Journal:  J Subst Abuse       Date:  1997

7.  A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).

Authors:  M D Shanahan; C M Doran; E Digiusto; J Bell; N Lintzeris; J White; R Ali; J B Saunders; R P Mattick; S Gilmour
Journal:  Addict Behav       Date:  2005-06-21       Impact factor: 3.913

Review 8.  The cost-effectiveness of methadone maintenance as a health care intervention.

Authors:  P G Barnett
Journal:  Addiction       Date:  1999-04       Impact factor: 6.526

9.  Buprenorphine versus methadone maintenance: a cost-effectiveness analysis.

Authors:  Christopher M Doran; Marian Shanahan; Richard P Mattick; Robert Ali; Jason White; James Bell
Journal:  Drug Alcohol Depend       Date:  2003-09-10       Impact factor: 4.492

10.  Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.

Authors:  Ramin Mojtabai; Joshua Graff Zivin
Journal:  Health Serv Res       Date:  2003-02       Impact factor: 3.402

View more
  14 in total

1.  The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California.

Authors:  Emanuel Krebs; Darren Urada; Elizabeth Evans; David Huang; Yih-Ing Hser; Bohdan Nosyk
Journal:  Addiction       Date:  2017-02-06       Impact factor: 6.526

2.  The Value of Shorter Initial Opioid Prescriptions: A Simulation Evaluation.

Authors:  Margrét V Bjarnadóttir; David R Anderson; Kislaya Prasad; Ritu Agarwal; D Alan Nelson
Journal:  Pharmacoeconomics       Date:  2020-01       Impact factor: 4.981

3.  Assessing Differences in the Availability of Opioid Addiction Therapy Options: Rural Versus Urban and American Indian Reservation Versus Nonreservation.

Authors:  Katherine A Hirchak; Sean M Murphy
Journal:  J Rural Health       Date:  2016-03-14       Impact factor: 4.333

4.  Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future.

Authors:  Ali Jalali; Danielle A Ryan; Kathryn E McCollister; Lisa A Marsch; Bruce R Schackman; Sean M Murphy
Journal:  J Subst Abuse Treat       Date:  2020-03

5.  The cost-effectiveness of Vancouver's supervised injection facility.

Authors:  Ahmed M Bayoumi; Gregory S Zaric
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262

6.  Dynamics in the costs of criminality among opioid dependent individuals.

Authors:  Emanuel Krebs; Thomas Kerr; Julio Montaner; Evan Wood; Bohdan Nosyk
Journal:  Drug Alcohol Depend       Date:  2014-09-22       Impact factor: 4.492

7.  Benefit-cost analysis of SBIRT interventions for substance using patients in emergency departments.

Authors:  Brady P Horn; Cameron Crandall; Alyssa Forcehimes; Michael T French; Michael Bogenschutz
Journal:  J Subst Abuse Treat       Date:  2017-05-04

Review 8.  Economic Evaluations of Opioid Use Disorder Interventions.

Authors:  Sean M Murphy; Daniel Polsky
Journal:  Pharmacoeconomics       Date:  2016-09       Impact factor: 4.981

9.  Economic Evaluation in Opioid Modeling: Systematic Review.

Authors:  Elizabeth Beaulieu; Catherine DiGennaro; Erin Stringfellow; Ava Connolly; Ava Hamilton; Ayaz Hyder; Magdalena Cerdá; Katherine M Keyes; Mohammad S Jalali
Journal:  Value Health       Date:  2020-10-26       Impact factor: 5.725

10.  Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review.

Authors:  Erica N Onuoha; Jared A Leff; Bruce R Schackman; Kathryn E McCollister; Daniel Polsky; Sean M Murphy
Journal:  Value Health       Date:  2021-05-08       Impact factor: 5.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.